• Join
  • Login
  • Contact

Search abstracts

Criteria for patient access of new technologies: Impact on regulatory sciences

  • At: Amsterdam (the Netherlands) (2012)
  • Type: Presentation
  • By: LEUFKENS, Bert (Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands)
  • Abstract:

    Weighing the benefit-risk balance of medicines thorough their lifecycle is a complex challenge given the evidence that is needed to take a justified decision in an area that is full of uncertainties on clinical benefits, possible safety concerns and long-term outcomes. Over the last decades an increasing mass of science, assessment methods and


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses